Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Randomized Open-Label, Phase 1b Study of the Safety of Pirfenidone Solution for Inhalation (AP01) in Patients with Idiopathic Pulmonary Fibrosis (ATLAS Study)
Glaspole, Ian
(Primary Chief Investigator (PCI))
Symons, Karen M.
(Project Manager)
School of Translational Medicine
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
7/06/19
→
1/06/22
View all
View less
Keywords
respiratory medicine
Idiopathic pulmonary fibrosis
Clinical trial